Skip to main content
Erschienen in: Endocrine 2/2018

23.08.2018 | Original Article

The roles of endothelial nitric oxide synthase gene polymorphisms in diabetes mellitus and its associated vascular complications: a systematic review and meta-analysis

verfasst von: Jinnan Dong, Yu Ping, Yuhong Wang, Yang Zhang

Erschienen in: Endocrine | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The roles of endothelial nitric oxide synthase (eNOS) gene polymorphisms in diabetes mellitus (DM) were intensively analyzed, but the results of these studies were inconsistent. Therefore, we performed this study to better assess the relationship between eNOS genetic variations and DM.

Methods

Eligible studies were searched in PubMed, Medline, Embase, and Web of Science. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess correlations between eNOS polymorphisms and DM.

Results

A total of 91 studies were finally included in our analyses. Significant associations with the susceptibility to DM were detected for the rs891512, rs1799983, rs2070744, and rs869109213 polymorphisms. As for vascular complications in DM, significant associations with the susceptibility to diabetic nephropathy were detected for the rs1799983 and rs2070744 polymorphisms. In addition, we also found that the rs1799983 polymorphism was significantly associated with the susceptibility to peripheral artery disease, whereas the rs2070744 polymorphism was significantly associated with the susceptibility to coronary artery disease in DM patients. Further subgroup analyses on the basis of type of disease and ethnicity of participants showed similar positive results.

Conclusions

In conclusion, our findings indicate that rs891512, rs1799983, rs2070744, and rs869109213 polymorphisms may serve as genetic biomarkers of DM, while rs1799983, rs2070744, and rs869109213 polymorphisms may contribute to the development of vascular complications in DM.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat D.J. Moore, J.M. Gregory, Y.A. Kumah-Crystal, J.H. Simmons, Mitigating micro-and macro-vascular complications of diabetes beginning in adolescence. Vasc. Health Risk. Manag. 5, 1015–1031 (2009)PubMedPubMedCentral D.J. Moore, J.M. Gregory, Y.A. Kumah-Crystal, J.H. Simmons, Mitigating micro-and macro-vascular complications of diabetes beginning in adolescence. Vasc. Health Risk. Manag. 5, 1015–1031 (2009)PubMedPubMedCentral
2.
Zurück zum Zitat American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 37(Suppl 1), S81–S90 (2014)CrossRef American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 37(Suppl 1), S81–S90 (2014)CrossRef
3.
Zurück zum Zitat A.K. Papazafiropoulou, N. Papanas, A. Melidonis, E. Maltezos, Family History of type 2 diabetes: Does having a diabetic parent increase the risk? Curr. Diabetes Rev. 13, 19–25 (2017)CrossRef A.K. Papazafiropoulou, N. Papanas, A. Melidonis, E. Maltezos, Family History of type 2 diabetes: Does having a diabetic parent increase the risk? Curr. Diabetes Rev. 13, 19–25 (2017)CrossRef
4.
Zurück zum Zitat K.J. Gaulton, Mechanisms of type 2 diabetes risk loci. Curr. Diab. Rep. 17, 72 (2017)CrossRef K.J. Gaulton, Mechanisms of type 2 diabetes risk loci. Curr. Diab. Rep. 17, 72 (2017)CrossRef
6.
Zurück zum Zitat M. Tsutsui, H. Shimokawa, T. Morishita, Y. Nakashima, N. Yanagihara, Development of genetically engineered mice lacking all three nitric oxide synthases. J. Pharmacol. Sci. 102, 147–154 (2006)CrossRef M. Tsutsui, H. Shimokawa, T. Morishita, Y. Nakashima, N. Yanagihara, Development of genetically engineered mice lacking all three nitric oxide synthases. J. Pharmacol. Sci. 102, 147–154 (2006)CrossRef
7.
Zurück zum Zitat H. Li, T. Wallerath, T. Münzel, U. Förstermann, Regulation of endothelial-type NO synthase expression in pathophysiology and in response to drugs. Nitric Oxide 7, 149–164 (2002)CrossRef H. Li, T. Wallerath, T. Münzel, U. Förstermann, Regulation of endothelial-type NO synthase expression in pathophysiology and in response to drugs. Nitric Oxide 7, 149–164 (2002)CrossRef
8.
Zurück zum Zitat D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman, PRISMA group, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann. Intern. Med. 151, 264–269 (2009)CrossRef D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman, PRISMA group, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann. Intern. Med. 151, 264–269 (2009)CrossRef
9.
Zurück zum Zitat A. Stang, Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur. J. Epidemiol. 25, 603–605 (2010)CrossRef A. Stang, Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur. J. Epidemiol. 25, 603–605 (2010)CrossRef
10.
Zurück zum Zitat D.M. Nathan, Diabetes: advances in diagnosis and treatment. JAMA 314, 1052–1062 (2015)CrossRef D.M. Nathan, Diabetes: advances in diagnosis and treatment. JAMA 314, 1052–1062 (2015)CrossRef
11.
Zurück zum Zitat GBD 2013 Mortality and Causes of Death Collaborators, Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385, 117–171 (2015)CrossRef GBD 2013 Mortality and Causes of Death Collaborators, Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385, 117–171 (2015)CrossRef
12.
Zurück zum Zitat C.J. Murray, C. Atkinson, K. Bhalla, G. Birbeck, R. Burstein, D. Chou et al.The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA 310, 591–608 (2013)CrossRef C.J. Murray, C. Atkinson, K. Bhalla, G. Birbeck, R. Burstein, D. Chou et al.The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA 310, 591–608 (2013)CrossRef
13.
Zurück zum Zitat K. Antosik, M. Borowiec, Genetic factors of diabetes. Arch. Immunol. Ther. Exp. (Warsz.) 64(Suppl 1), 157–160 (2016)CrossRef K. Antosik, M. Borowiec, Genetic factors of diabetes. Arch. Immunol. Ther. Exp. (Warsz.) 64(Suppl 1), 157–160 (2016)CrossRef
14.
Zurück zum Zitat H.H. Hoang, S.V. Padgham, C.J. Meininger, L-arginine, tetrahydrobiopterin, nitric oxide and diabetes. Curr. Opin. Clin. Nutr. Metab. Care 16, 76–82 (2016)CrossRef H.H. Hoang, S.V. Padgham, C.J. Meininger, L-arginine, tetrahydrobiopterin, nitric oxide and diabetes. Curr. Opin. Clin. Nutr. Metab. Care 16, 76–82 (2016)CrossRef
15.
Zurück zum Zitat T. Nakagawa, R.J. Johnson, Endothelial nitric oxide synthase. Contrib. Nephrol. 170, 93–101 (2011)CrossRef T. Nakagawa, R.J. Johnson, Endothelial nitric oxide synthase. Contrib. Nephrol. 170, 93–101 (2011)CrossRef
16.
Zurück zum Zitat B.S. Dellamea, L.C. Pinto, C.B. Leitão, K.G. Santos, L.H. Canani, Endothelial nitric oxide synthase gene polymorphisms and risk of diabetic nephropathy: a systematic review and meta-analysis. BMC Med. Genet. 15, 9 (2014)CrossRef B.S. Dellamea, L.C. Pinto, C.B. Leitão, K.G. Santos, L.H. Canani, Endothelial nitric oxide synthase gene polymorphisms and risk of diabetic nephropathy: a systematic review and meta-analysis. BMC Med. Genet. 15, 9 (2014)CrossRef
17.
Zurück zum Zitat Z. Jia, X. Zhang, S. Kang, Y. Wu, Association of endothelial nitric oxide synthase gene polymorphisms with type 2 diabetes mellitus: a meta-analysis. Endocr. J. 60, 893–901 (2013)CrossRef Z. Jia, X. Zhang, S. Kang, Y. Wu, Association of endothelial nitric oxide synthase gene polymorphisms with type 2 diabetes mellitus: a meta-analysis. Endocr. J. 60, 893–901 (2013)CrossRef
18.
Zurück zum Zitat S. Zhao, T. Li, B. Zheng, Z. Zheng, Nitric oxide synthase 3 (NOS3) 4b/a, T-786C and G894T polymorphisms in association with diabetic retinopathy susceptibility: a meta-analysis. Ophthalmic Genet. 33, 200–207 (2012)CrossRef S. Zhao, T. Li, B. Zheng, Z. Zheng, Nitric oxide synthase 3 (NOS3) 4b/a, T-786C and G894T polymorphisms in association with diabetic retinopathy susceptibility: a meta-analysis. Ophthalmic Genet. 33, 200–207 (2012)CrossRef
19.
Zurück zum Zitat Y. He, Z. Fan, J. Zhang, Q. Zhang, M. Zheng, Y. Li, D. Zhang, S. Gu, H. Yang, Polymorphisms of eNOS gene are associated with diabetic nephropathy: a meta-analysis. Mutagenesis 26, 339–349 (2011)CrossRef Y. He, Z. Fan, J. Zhang, Q. Zhang, M. Zheng, Y. Li, D. Zhang, S. Gu, H. Yang, Polymorphisms of eNOS gene are associated with diabetic nephropathy: a meta-analysis. Mutagenesis 26, 339–349 (2011)CrossRef
Metadaten
Titel
The roles of endothelial nitric oxide synthase gene polymorphisms in diabetes mellitus and its associated vascular complications: a systematic review and meta-analysis
verfasst von
Jinnan Dong
Yu Ping
Yuhong Wang
Yang Zhang
Publikationsdatum
23.08.2018
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 2/2018
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-018-1683-4

Weitere Artikel der Ausgabe 2/2018

Endocrine 2/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.